180 related articles for article (PubMed ID: 27940184)
1. SiRNA-mediated in vivo gene knockdown by acid-degradable cationic nanohydrogel particles.
Leber N; Kaps L; Aslam M; Schupp J; Brose A; Schäffel D; Fischer K; Diken M; Strand D; Koynov K; Tuettenberg A; Nuhn L; Zentel R; Schuppan D
J Control Release; 2017 Feb; 248():10-23. PubMed ID: 27940184
[TBL] [Abstract][Full Text] [Related]
2. In Vivo Gene-Silencing in Fibrotic Liver by siRNA-Loaded Cationic Nanohydrogel Particles.
Kaps L; Nuhn L; Aslam M; Brose A; Foerster F; Rosigkeit S; Renz P; Heck R; Kim YO; Lieberwirth I; Schuppan D; Zentel R
Adv Healthc Mater; 2015 Dec; 4(18):2809-15. PubMed ID: 26627192
[TBL] [Abstract][Full Text] [Related]
3. Size-dependent knockdown potential of siRNA-loaded cationic nanohydrogel particles.
Nuhn L; Tomcin S; Miyata K; Mailänder V; Landfester K; Kataoka K; Zentel R
Biomacromolecules; 2014 Nov; 15(11):4111-21. PubMed ID: 25338185
[TBL] [Abstract][Full Text] [Related]
4. Cationic Nanohydrogel Particles for Therapeutic Oligonucleotide Delivery.
Leber N; Nuhn L; Zentel R
Macromol Biosci; 2017 Oct; 17(10):. PubMed ID: 28605133
[TBL] [Abstract][Full Text] [Related]
5. Degradable cationic nanohydrogel particles for stimuli-responsive release of siRNA.
Nuhn L; Braun L; Overhoff I; Kelsch A; Schaeffel D; Koynov K; Zentel R
Macromol Rapid Commun; 2014 Dec; 35(24):2057-64. PubMed ID: 25323454
[TBL] [Abstract][Full Text] [Related]
6. In Vivo siRNA Delivery to Immunosuppressive Liver Macrophages by α-Mannosyl-Functionalized Cationic Nanohydrogel Particles.
Kaps L; Leber N; Klefenz A; Choteschovsky N; Zentel R; Nuhn L; Schuppan D
Cells; 2020 Aug; 9(8):. PubMed ID: 32824208
[TBL] [Abstract][Full Text] [Related]
7. Cationic nanohydrogel particles as potential siRNA carriers for cellular delivery.
Nuhn L; Hirsch M; Krieg B; Koynov K; Fischer K; Schmidt M; Helm M; Zentel R
ACS Nano; 2012 Mar; 6(3):2198-214. PubMed ID: 22381078
[TBL] [Abstract][Full Text] [Related]
8. α-Mannosyl-Functionalized Cationic Nanohydrogel Particles for Targeted Gene Knockdown in Immunosuppressive Macrophages.
Leber N; Kaps L; Yang A; Aslam M; Giardino M; Klefenz A; Choteschovsky N; Rosigkeit S; Mostafa A; Nuhn L; Schuppan D; Zentel R
Macromol Biosci; 2019 Jul; 19(7):e1900162. PubMed ID: 31173461
[TBL] [Abstract][Full Text] [Related]
9. Degradable poly(ethylene glycol) (PEG)-based hydrogels for spatiotemporal control of siRNA/nanoparticle delivery.
Wang Y; Zhang S; Benoit DSW
J Control Release; 2018 Oct; 287():58-66. PubMed ID: 30077736
[TBL] [Abstract][Full Text] [Related]
10. Acid-degradable cationic poly(ketal amidoamine) for enhanced RNA interference in vitro and in vivo.
Lim H; Noh J; Kim Y; Kim H; Kim J; Khang G; Lee D
Biomacromolecules; 2013 Jan; 14(1):240-7. PubMed ID: 23240892
[TBL] [Abstract][Full Text] [Related]
11. Overcoming the barrier of CD8
Tabujew I; Willig M; Leber N; Freidel C; Negwer I; Koynov K; Helm M; Landfester K; Zentel R; Peneva K; Mailänder V
Acta Biomater; 2019 Dec; 100():338-351. PubMed ID: 31586726
[TBL] [Abstract][Full Text] [Related]
12. Dual mode polyspermine with tunable degradability for plasmid DNA and siRNA delivery.
Shim MS; Kwon YJ
Biomaterials; 2011 Jun; 32(16):4009-20. PubMed ID: 21371749
[TBL] [Abstract][Full Text] [Related]
13. Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo.
Sato Y; Hashiba K; Sasaki K; Maeki M; Tokeshi M; Harashima H
J Control Release; 2019 Feb; 295():140-152. PubMed ID: 30610950
[TBL] [Abstract][Full Text] [Related]
14. Design and evaluation of new pH-sensitive amphiphilic cationic lipids for siRNA delivery.
Malamas AS; Gujrati M; Kummitha CM; Xu R; Lu ZR
J Control Release; 2013 Nov; 171(3):296-307. PubMed ID: 23796431
[TBL] [Abstract][Full Text] [Related]
15. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C
Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295
[TBL] [Abstract][Full Text] [Related]
16. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
17. Self-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery.
Sun TM; Du JZ; Yan LF; Mao HQ; Wang J
Biomaterials; 2008 Nov; 29(32):4348-55. PubMed ID: 18715636
[TBL] [Abstract][Full Text] [Related]
18. Aggregation behavior of cationic nanohydrogel particles in human blood serum.
Nuhn L; Gietzen S; Mohr K; Fischer K; Toh K; Miyata K; Matsumoto Y; Kataoka K; Schmidt M; Zentel R
Biomacromolecules; 2014 Apr; 15(4):1526-33. PubMed ID: 24697603
[TBL] [Abstract][Full Text] [Related]
19. Acid-degradable polymer-caged lipoplex (PCL) platform for siRNA delivery: facile cellular triggered release of siRNA.
Hong BJ; Chipre AJ; Nguyen ST
J Am Chem Soc; 2013 Nov; 135(47):17655-8. PubMed ID: 24000948
[TBL] [Abstract][Full Text] [Related]
20. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
